Compare, Analyse Jubilant Pharmova with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT PHARMOVA    TEVA PHARMA
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
TEVA PHARMA
Dec-13
JUBILANT PHARMOVA /
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7273,098-   
Low Rs2302,691-   
Sales per share (Unadj.) Rs574.71,777.7-  
Earnings per share (Unadj.) Rs56.4111.1-  
Cash flow per share (Unadj.) Rs85.4254.7-  
Dividends per share (Unadj.) Rs5.0097.22-  
Dividend yield (eoy) %1.03.4 31.1%  
Book value per share (Unadj.) Rs351.81,974.7-  
Shares outstanding (eoy) m159.28848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.81.6 51.1%   
Avg P/E ratio x8.526.1 32.6%  
P/CF ratio (eoy) x5.611.4 49.3%  
Price / Book Value ratio x1.41.5 92.8%  
Dividend payout %8.987.5 10.1%   
Avg Mkt Cap Rs m76,2202,454,273 3.1%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m21,2770-   
Avg. sales/employee Rs ThNM33,541.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,095.3-  
INCOME DATA
Net Sales Rs m91,5441,507,502 6.1%  
Other income Rs m4740-   
Total revenues Rs m92,0181,507,502 6.1%   
Gross profit Rs m19,124412,830 4.6%  
Depreciation Rs m4,619121,853 3.8%   
Interest Rs m2,87429,610 9.7%   
Profit before tax Rs m12,105261,368 4.6%   
Minority Interest Rs m01,187 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-171,574 0.0%   
Tax Rs m3,123-3,191 -97.9%   
Profit after tax Rs m8,98294,172 9.5%  
Gross profit margin %20.927.4 76.3%  
Effective tax rate %25.8-1.2 -2,113.0%   
Net profit margin %9.86.2 157.1%  
BALANCE SHEET DATA
Current assets Rs m50,3831,018,161 4.9%   
Current liabilities Rs m26,190887,923 2.9%   
Net working cap to sales %26.48.6 305.9%  
Current ratio x1.91.1 167.8%  
Inventory Days Days791 7.2%  
Debtors Days Days5296 53.8%  
Net fixed assets Rs m72,721492,383 14.8%   
Share capital Rs m1593,711 4.3%   
"Free" reserves Rs m55,8800-   
Net worth Rs m56,0391,674,549 3.3%   
Long term debt Rs m37,397770,819 4.9%   
Total assets Rs m123,1043,445,125 3.6%  
Interest coverage x5.29.8 53.0%   
Debt to equity ratio x0.70.5 145.0%  
Sales to assets ratio x0.70.4 169.9%   
Return on assets %9.63.6 268.1%  
Return on equity %16.05.6 285.0%  
Return on capital %16.04.9 325.1%  
Exports to sales %00-   
Imports to sales %14.80-   
Net fx Rs m2,0000-   
CASH FLOW
From Operations Rs m15,429240,218 6.4%  
From Investments Rs m-3,270-85,119 3.8%  
From Financial Activity Rs m-10,504-288,157 3.6%  
Net Cashflow Rs m2,254-133,059 -1.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.21 Rs / USD

Compare JUBILANT PHARMOVA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare JUBILANT PHARMOVA With: GODAVARI DRU  BH.IMMUN&BIO  ZIM LABORATORIES  CAPLIN POINT  JENBURKT PH.  



Today's Market

Sensex, Nifty Recover from Day's Low to End Flat; Adani Ports and Bajaj Auto Among Top Gainers(Closing)

Indian share markets recouped early losses during closing hours and ended today's volatile session on a flat note.

Related Views On News

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Points to Keep in Mind Before Subscribing to Krishna Institute of Medical Sciences' IPO (Views On News)

Jun 15, 2021

All you need to know about the IPO of Krishna Institute of Medical Sciences.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments (Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth (Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

JUBILANT PHARMOVA SHARE PRICE


Jun 18, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 8-QTR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS